Literature DB >> 6465331

Accumulation of nonesterified fatty acids in ischemic canine myocardium.

F W Prinzen, G J Van der Vusse, T Arts, T H Roemen, W A Coumans, R S Reneman.   

Abstract

In ischemic myocardium the time course of nonesterified fatty acid (NEFA) accumulation was studied in relation to changes in regional metabolism and mechanics. In open-chest dogs a coronary artery was partially occluded for 120 min. In the ischemic myocardium no increase was observed in NEFA content within 10 min, whereas changes were found in regional shortening, high-energy phosphate content, and glucose arteriologcal venous difference. During prolonged ischemia NEFA content increased, the highest values being found in the inner and middle layers after 120 min (112 and 85 nmol X g-1, respectively; control values 30); the value in the outer layers after 60 min was 93 nmol X g-1. After 120 min of ischemia, accumulation of NEFA generally occurred when myocardial blood flow was below 0.3 ml X min-1 X g-1 and ATP content was below 10 mumol X g dry wt-1. Under these circumstances the individual NEFA with the highest relative increase was arachidonic acid. The present findings indicate that the changes in mechanical function and metabolism, as observed in myocardium rendered ischemic for 10 min, are not caused by increased NEFA content and that NEFA accumulation may partly result from hydrolysis of glycerophospholipids.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6465331     DOI: 10.1152/ajpheart.1984.247.2.H264

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  22 in total

1.  Discrepancies between myocardial blood flow and fiber shortening in the ischemic border zone as assessed with video mapping of epicardial deformation.

Authors:  F W Prinzen; T Arts; A P Hoeks; R S Reneman
Journal:  Pflugers Arch       Date:  1989-11       Impact factor: 3.657

2.  Degradation of phospholipids and triacylglycerol, and accumulation of fatty acids in anoxic myocardial tissue, disrupted by freeze-thawing.

Authors:  G J van der Vusse; M J de Groot; P H Willemsen; M van Bilsen; A H Schrijvers; R S Reneman
Journal:  Mol Cell Biochem       Date:  1989 Jun 27-Jul 24       Impact factor: 3.396

3.  Sarcolemmal integrity during ischaemia and reperfusion of the isolated rat heart.

Authors:  I S Harper; A Lochner
Journal:  Basic Res Cardiol       Date:  1989 Mar-Apr       Impact factor: 17.165

Review 4.  Hormones and triacylglycerol metabolism under normoxic and ischemic conditions.

Authors:  K Schoonderwoerd; T van der Kraaij; W C Hülsmann; H Stam
Journal:  Mol Cell Biochem       Date:  1989 Jun 27-Jul 24       Impact factor: 3.396

5.  Enhanced lipolysis of myocardial triglycerides during low-flow ischemia and anoxia in the isolated rat heart.

Authors:  K Schoonderwoerd; S Broekhoven-Schokker; W C Hülsmann; H Stam
Journal:  Basic Res Cardiol       Date:  1989 Mar-Apr       Impact factor: 17.165

6.  A new method for studying the incorporation of nonesterified fatty acids into cardiac lipids by using deuterium-labelled palmitate.

Authors:  J F Hütter; C Schweickhardt; D H Hunneman; H M Piper; P G Spieckermann
Journal:  Basic Res Cardiol       Date:  1988 Jan-Feb       Impact factor: 17.165

7.  Arachidonic acid metabolism in cultured adult myocardial cells under short-time hypoxic conditions.

Authors:  B Härtel; R Morwinski; D Heydeck; B Papies
Journal:  Mol Cell Biochem       Date:  1991-07-24       Impact factor: 3.396

8.  Lysosomal lipolytic enzymes, lipid peroxidation, and injury.

Authors:  B F Dickens; I T Mak; W B Weglicki
Journal:  Mol Cell Biochem       Date:  1988 Jul-Aug       Impact factor: 3.396

9.  Lysophospholipids do not directly modulate Na(+)-H+ exchange.

Authors:  Danny P Goel; L David A Ford; Grant N Pierce
Journal:  Mol Cell Biochem       Date:  2003-09       Impact factor: 3.396

10.  Effects of POCA on metabolism and function in the ischemic rat heart.

Authors:  D J Paulson; J J Noonan; K M Ward; H Stanley; A Sherratt; A L Shug
Journal:  Basic Res Cardiol       Date:  1986 Mar-Apr       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.